2025 Q4 -tulosraportti
74 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Viimeisin osinko
4,49%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 100 | - | - | ||
| 100 | - | - | ||
| 200 | - | - | ||
| 100 | - | - | ||
| 100 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·4 t sittenI wrote this post the other day. "It's really pushing in the USA to move the price upwards just like yesterday and is currently 2 kr above the Danish listing." For some days there in the USA, it had indicated that it would go up, where the Danish listing only moved a little. Quickly a comment comes, about why one cares about 2 kr - it's a waste of time. In half a year, I don't care if it rises 2 kr from e.g. 200 to 202, but after this long downturn from approx 1.000 kr (I was only in from 541), I think one is looking for the answer to whether 230-240 kr was the bottom (We'll find that out 6/5). If that's it, then I also believe that it will be heavily bought up. And I also believe that's why the Friday news about prescription sales is being followed so closely. One hopes that the bleeding has stopped. Many are sitting with a large ÷ and hoping for a rise, others have shorted and are hoping for a fall. Regardless of which boat one is in, I think it's a shame that some feel the need to trash others. Come with some links and arguments for the claim and let's discuss and become wiser....it might well be that the other group is right. Otherwise refrain from commenting 🙂
·6 t sittenNovo Nordisk will have a huge advantage after FDA has demanded new information from Eli Lilly after it has emerged that there is suspicion of liver damage. It can take Eli Lilly not months but years to document that there is no connection or is there !! Doctors will be reluctant to prescribe Eli Lilly prescriptions and that will benefit Novo not only for months but for years. Who dares to take Eli Lilly's pill or generic medicine.
·12 t sittenWhy are people constantly cheering for small capital gains. That doesn't benefit any of us unless one wants to exit the stock. Last week's increase of a small 10% has made Novo's own share buyback for 15 Mia kr 10% more expensive. In other words, it costs us 1.5 Mia kr. It is far better with a cheap stock where one can supplement regularly and get good dividend percentages. So, get in the game and stop talking up the stock.
·4 t sitten · MuokattuMany don't even know what the stock market is many think it only goes up and up. They should probably look for etf instead. There was also someone yesterday who wrote the price has fallen from 260 to 258 beware there will be a bloodbath from a drop of 1% We just have to scroll on as we almost always do. 😀
·1 t sittenI choose to remove the worst. Have a lot of grey bars. Novo's forum is thankfully by far the least informative on Nordnet. There are quite a few good forums, and I write with some people on Nordnet who know what investing is about, and who really have a grip on the market and which sectors deliver returns.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
74 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Viimeisin osinko
4,49%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·4 t sittenI wrote this post the other day. "It's really pushing in the USA to move the price upwards just like yesterday and is currently 2 kr above the Danish listing." For some days there in the USA, it had indicated that it would go up, where the Danish listing only moved a little. Quickly a comment comes, about why one cares about 2 kr - it's a waste of time. In half a year, I don't care if it rises 2 kr from e.g. 200 to 202, but after this long downturn from approx 1.000 kr (I was only in from 541), I think one is looking for the answer to whether 230-240 kr was the bottom (We'll find that out 6/5). If that's it, then I also believe that it will be heavily bought up. And I also believe that's why the Friday news about prescription sales is being followed so closely. One hopes that the bleeding has stopped. Many are sitting with a large ÷ and hoping for a rise, others have shorted and are hoping for a fall. Regardless of which boat one is in, I think it's a shame that some feel the need to trash others. Come with some links and arguments for the claim and let's discuss and become wiser....it might well be that the other group is right. Otherwise refrain from commenting 🙂
- ·6 t sittenNovo Nordisk will have a huge advantage after FDA has demanded new information from Eli Lilly after it has emerged that there is suspicion of liver damage. It can take Eli Lilly not months but years to document that there is no connection or is there !! Doctors will be reluctant to prescribe Eli Lilly prescriptions and that will benefit Novo not only for months but for years. Who dares to take Eli Lilly's pill or generic medicine.
- ·12 t sittenWhy are people constantly cheering for small capital gains. That doesn't benefit any of us unless one wants to exit the stock. Last week's increase of a small 10% has made Novo's own share buyback for 15 Mia kr 10% more expensive. In other words, it costs us 1.5 Mia kr. It is far better with a cheap stock where one can supplement regularly and get good dividend percentages. So, get in the game and stop talking up the stock.·4 t sitten · MuokattuMany don't even know what the stock market is many think it only goes up and up. They should probably look for etf instead. There was also someone yesterday who wrote the price has fallen from 260 to 258 beware there will be a bloodbath from a drop of 1% We just have to scroll on as we almost always do. 😀·1 t sittenI choose to remove the worst. Have a lot of grey bars. Novo's forum is thankfully by far the least informative on Nordnet. There are quite a few good forums, and I write with some people on Nordnet who know what investing is about, and who really have a grip on the market and which sectors deliver returns.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 100 | - | - | ||
| 100 | - | - | ||
| 200 | - | - | ||
| 100 | - | - | ||
| 100 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
2025 Q4 -tulosraportti
74 päivää sitten
‧1 t 12 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
7,95 DKK/osake
Viimeisin osinko
4,49%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·4 t sittenI wrote this post the other day. "It's really pushing in the USA to move the price upwards just like yesterday and is currently 2 kr above the Danish listing." For some days there in the USA, it had indicated that it would go up, where the Danish listing only moved a little. Quickly a comment comes, about why one cares about 2 kr - it's a waste of time. In half a year, I don't care if it rises 2 kr from e.g. 200 to 202, but after this long downturn from approx 1.000 kr (I was only in from 541), I think one is looking for the answer to whether 230-240 kr was the bottom (We'll find that out 6/5). If that's it, then I also believe that it will be heavily bought up. And I also believe that's why the Friday news about prescription sales is being followed so closely. One hopes that the bleeding has stopped. Many are sitting with a large ÷ and hoping for a rise, others have shorted and are hoping for a fall. Regardless of which boat one is in, I think it's a shame that some feel the need to trash others. Come with some links and arguments for the claim and let's discuss and become wiser....it might well be that the other group is right. Otherwise refrain from commenting 🙂
- ·6 t sittenNovo Nordisk will have a huge advantage after FDA has demanded new information from Eli Lilly after it has emerged that there is suspicion of liver damage. It can take Eli Lilly not months but years to document that there is no connection or is there !! Doctors will be reluctant to prescribe Eli Lilly prescriptions and that will benefit Novo not only for months but for years. Who dares to take Eli Lilly's pill or generic medicine.
- ·12 t sittenWhy are people constantly cheering for small capital gains. That doesn't benefit any of us unless one wants to exit the stock. Last week's increase of a small 10% has made Novo's own share buyback for 15 Mia kr 10% more expensive. In other words, it costs us 1.5 Mia kr. It is far better with a cheap stock where one can supplement regularly and get good dividend percentages. So, get in the game and stop talking up the stock.·4 t sitten · MuokattuMany don't even know what the stock market is many think it only goes up and up. They should probably look for etf instead. There was also someone yesterday who wrote the price has fallen from 260 to 258 beware there will be a bloodbath from a drop of 1% We just have to scroll on as we almost always do. 😀·1 t sittenI choose to remove the worst. Have a lot of grey bars. Novo's forum is thankfully by far the least informative on Nordnet. There are quite a few good forums, and I write with some people on Nordnet who know what investing is about, and who really have a grip on the market and which sectors deliver returns.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 100 | - | - | ||
| 100 | - | - | ||
| 200 | - | - | ||
| 100 | - | - | ||
| 100 | - | - |
Välittäjätilasto
Dataa ei löytynyt